Related Experiment Video
Updated: Aug 20, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
R1, a novel repressor of the human monoamine oxidase A
Kevin Chen1, Xiao-Ming Ou, Gao Chen
1Department of Molecular Pharmacology and Toxicology, School of Pharmacy, University of California, Los Angeles, California 90033, USA.
Abstract:
Monoamine oxidase catalyzes the oxidative deamination of a number of neurotransmitters. A deficiency in monoamine oxidase A results in aggressive behavior in both humans and mice. Studies on the regulation of monoamine oxidase A gene expression have shown that the Sp1 family is important for monoamine oxidase A expression. To search for novel transcription factors, the sequences of three Sp1 sites in the monoamine oxidase A core promoter were used in the yeast one-hybrid system to screen a human cDNA library. A novel repressor, R1 (RAM2), has been cloned. The R1 cDNA encodes a protein with 454 amino acids and an open reading frame at the 5'-end. The transfection of R1 in a human neuroblastoma cell line, SK-N-BE (2)-C, inhibited the monoamine oxidase A promoter and enzymatic activity. The degree of inhibition of monoamine oxidase A by R1 correlated with the level of R1 protein expression. R1 was also found to repress monoamine oxidase A promoter activity within a natural chromatin environment. A gel-shift assay indicated that the endogenous R1 protein in SK-N-BE (2)-C cells interacted with the R1 binding sequence. R1 also bound directly to the natural monoamine oxidase A promoter in vivo as shown by chromatin immunoprecipitation assay. Immunocytochemical analysis showed that R1 was expressed in both cytosol and nucleus, which suggested a role for R1 in transcriptional regulation. Northern blot analysis revealed the presence of endogenous R1 mRNA in human brain and peripheral tissues. Taken together, this study shows that R1 is a novel repressor that inhibits monoamine oxidase A gene expression.
Insights
A novel repressor protein, R1 (RAM2), has been identified that inhibits monoamine oxidase A (MAO-A) gene expression. This discovery sheds light on the regulation of MAO-A, a key enzyme in neurotransmitter metabolism.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Monoamine oxidase (MAO) enzymes are crucial for neurotransmitter metabolism.
- A deficiency in monoamine oxidase A (MAO-A) is linked to aggressive behavior.
- Sp1 transcription factors are known regulators of MAO-A gene expression.
Purpose of the Study:
- To identify novel transcription factors regulating MAO-A gene expression.
- To characterize a newly discovered repressor protein, R1 (RAM2).
Main Methods:
- Yeast one-hybrid screening of a human cDNA library using MAO-A promoter sequences.
- Transfection assays in human neuroblastoma cells (SK-N-BE (2)-C).
- Gel-shift assays and chromatin immunoprecipitation (ChIP) assays.
Main Results:
- A novel repressor, R1 (RAM2), was cloned and characterized.
- R1 inhibited MAO-A promoter activity and enzymatic function in a dose-dependent manner.
- R1 directly binds to the MAO-A promoter in vitro and in vivo, functioning as a transcriptional repressor.
Conclusions:
- R1 (RAM2) is a novel repressor of monoamine oxidase A gene expression.
- R1's nuclear and cytosolic localization suggests a role in transcriptional regulation.
- R1 mRNA is expressed in human brain and peripheral tissues, indicating its physiological relevance.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Antidepressant Drugs: MAOIs and Other Agents
Co-activators and Co-repressors
Drugs Affecting Neurotransmitter Release or Uptake
Repressible Operon: trp Operon
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...

